bg
A

Allakos (ALLK)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allakos (ALLK)

Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more

  • USD2.41
  • USD2.46
  • USD2.19
  • USD8.73
  • -21.50%
  • --
  • 922.03k
  • 1.49M
  • 189M
  • 2.02
  • -59.50%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.